Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
243
self-reported 51–200 band
Founded
1999
27 years
Legal entities
1
ABR
Office countries
3
3 addresses
Funding rounds
None on record
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
COGSTATE LTD
ABN80090975723
Legal entities
Show as table · Cogstate: 1 registry entity
| COGSTATE LTD | ABN 80090975723 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
The brain is central to every aspect of our lives, yet it isn’t monitored with the same consistency and proactivity as other vital signs. As a neuroscience technology company, we believe that better brain health insights lead to better brain health outcomes. That's why we're on a mission to democratize cognitive health by radically simplifying the way it is measured.
For more than 20 years, we’ve proudly supported the research needs of biopharmaceutical companies and academic institutions, and the clinical care needs of physicians and individuals around the world. We create easy to use digital tests that provide rapid, reliable, and science-backed results and offer solutions that support the highest fidelity measurements possible.
We believe our team members should have flexibility as to how, when, and where they work. We work flexibly to support our global team, who mostly work from home––and offer opportunities for face-to-face collaboration at our offices in New Haven, Melbourne, and London. Our team members also have access to co-working spaces around the world.
Specialties
All 19 specialties
- Cognitive Testing
- Healthcare
- Academic Research
- Remote Testing
- Alzheimer's Disease
- Dementia
- Rare Disease
- Central Nervous System
- Rater Training
- Neuroscience
- Concussion
- Parkinson's Disease
- Multiple Sclerosis
- Epilepsy
- Mood Disorders
- Schizophrenia
- Oncology
- Decentralized Clinical Trials
- Clinical Trials
Locations
3
Countries with an office address3 addresses on record
Country footprint
Show as table · Offices in 3 countries
| Countries | 3 |
|---|---|
| Primary country | AU |
All codes: AU GB US
Addresses
- AU367 Collins St; Level 32; Melbourne, Victoria 3000Primary
- GB1 Long Lane; Uncommon Borough; London, England SE1 4PG
- US195 Church Street; 4th Floor; New Haven, CT 06510
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Cogstate?
One Victoria entity on the ABR: COGSTATE LTD (ABN 80 090 975 723), high confidence.
How many people work at Cogstate?
243 counted staff profiles at January 2026, above the self-reported 51–200 band.
Where does Cogstate have offices?
Three addresses on record across 3 countries. Primary: 367 Collins St, Level 32, Melbourne, Victoria 3000.
Has Cogstate raised funding?
None linked to this brand.
What does Cogstate list as its specialties?
19 tags on the brand's own list, among them oncology, dementia and neuroscience.
Which companies are listed alongside Cogstate?
11 profiles list Cogstate as a peer — 84th percentile in Biotechnology Research. It lists ten peers of its own.